XML 52 R40.htm IDEA: XBRL DOCUMENT v3.20.2
STOCKHOLDERS' EQUITY - Narrative (Detail)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 05, 2020
USD ($)
Apr. 30, 2020
USD ($)
$ / shares
Apr. 30, 2019
USD ($)
$ / shares
shares
Sep. 30, 2019
shares
Sep. 30, 2020
USD ($)
shares
Sep. 30, 2019
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Proceeds from exercise of stock options and restricted stock units     $ 136,300   $ 1,187 $ 1,139
Biogen MA, Inc. | Stock Purchase Agreement            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Sale of stock, price per share (in dollars per share) | $ / shares   $ 9.2137        
Consideration received on transaction   $ 225,000        
Jefferies LLC | At The Market Offering Agreement            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Issuance of common stock under public offering, net of issuance costs (in shares) | shares         0  
Sale of stock, percentage of gross proceeds 0.03          
Stock offering program, maximum value $ 150,000          
Jefferies LLC | Maximum | At The Market Offering Agreement            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Payments of stock issuance costs $ 50          
Common Stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Issuance of common stock under public offering, net of issuance costs (in shares) | shares     12,700,000 24,420,157 12,650,000
Public offering price of common stock issued (in dollars per share) | $ / shares     $ 11.50